Journal Article Summary
The article investigates the safety, pharmacodynamics, and pharmacokinetics of a new immediate-release formulation of esomeprazole combined with sodium bicarbonate, designed to address the limitations of traditional enteric-coated esomeprazole. Esomeprazole is a widely used medication for treating acid-related disorders like gastroesophageal reflux disease (GERD), but its enteric-coated version can delay absorption and onset of action. By developing an immediate-release formulation, the researchers aimed to provide quicker relief for patients suffering from acid-related symptoms, which is crucial for improving treatment satisfaction and adherence.
In this study, 40 healthy male participants were randomly assigned to receive either the new formulation (20 mg esomeprazole with 800 mg sodium bicarbonate) or the standard enteric-coated esomeprazole for seven days. Blood samples were taken to analyze how the body absorbed the medication, and intragastric pH levels were monitored to assess acid suppression. The findings revealed that the immediate-release formulation led to a faster peak concentration of esomeprazole in the bloodstream compared to the enteric-coated version, while both formulations showed similar effectiveness in maintaining gastric pH levels above 4, indicating comparable acid suppression.
Despite the promising results, the study has limitations, including its focus solely on healthy adult males, which may not reflect the experiences of all patients with GERD. Additionally, the study did not measure serum gastrin levels, which could provide further insights into the drug's effects. Patients should consult their healthcare providers about the implications of these findings, especially if they are considering treatment options for acid-related disorders, as individual responses to medications can vary significantly.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Kim Dasohm, Park Min Soo, Yoo Byung Won, Hong Taegon, Park Shin Jung, Kim Choon Ok. The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male. Drug Design, Development and Therapy 2019. DOI: 10.2147/DDDT.S212491. PMID: 31564831. PMCID: PMC6731969.
Featured Pill Pals Product
Omeprazole 20 mg Capsules --- 30 Count --- Generic for Prilosec --- Xiromed Pharma
Omeprazole 20 mg Capsules — 30 Count — Generic for Prilosec — Xiromed Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
